Julie Miller Everett

Julie Miller Everett is an accomplished professional in the life sciences sector, currently serving as the Chief Business Officer at both BridgeBio and Eidos Therapeutics since September 2023. Previously, extensive experience at BioMarin Pharmaceutical Inc. included roles such as Global Commercial Lead for Enterprise Growth Strategy and Transformation, Executive Director of North America Brand Management, and Senior Director of PKU Marketing. Julie was also an Advisor at Sanaby Health from September 2021 to November 2022. With a background as a strategy consultant at Trinity Partners, expertise spans corporate strategy, brand planning, and market analytics for the pharmaceutical and biotechnology industries. Julie holds a Bachelor's degree with honors in Biology from Princeton University and an MBA with honors from the University of California, Berkeley, Haas School of Business.